Lilian Maritza Spencer (Lilian M Spencer)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Staphylococcus Aureus

Dendritic Cells

Plasmodium Falciparum

Top Venues

Methods and protocols

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mishell Ortiz, Hortensia María Rodríguez-Cabrera, Elisabetta Lucci, Julieta Coro, Beatriz Pernía, Abigail Montero-Calderon, Francisco Javier Tingo-Jácome, Leslie Espinoza, Lilian Maritza Spencer
Serological Cross-Reaction between Six Thiadiazine by Indirect ELISA Test and Their Antimicrobial Activity. Methods and protocols 6 (2) (2023)
Mishell Ortiz, Hortensia María Rodríguez-Cabrera, Elisabetta Lucci, Julieta Coro, Beatriz Pernía, Abigail Montero-Calderon, Francisco Javier Tingo-Jácome, Leslie Espinoza, Lilian Maritza Spencer
Serological Cross-Reaction between Six Thiadiazine by Indirect ELISA Test and Their Antimicrobial Activity. Methods and protocols 6 (2) (2023)
Mishell Ortiz, Hortensia María Rodríguez-Cabrera, Elisabetta Lucci, Julieta Coro, Beatriz Pernía, Abigail Montero-Calderon, Francisco Javier Tingo-Jácome, Leslie Espinoza, Lilian Maritza Spencer
Serological Cross-Reaction between Six Thiadiazine by Indirect ELISA Test and Their Antimicrobial Activity. Methods and protocols 6 (2) (2023)
Angibelle Lizmar Rodríguez Gil de Montes, Lilian Maritza Spencer
Chimeric antigen receptor T cells: immunotherapy for the treatment of leukemia, lymphoma and myeloma. Molecular cancer therapeutics (2023)
Mishell Ortiz, Hortensia María Rodríguez-Cabrera, Elisabetta Lucci, Julieta Coro, Beatriz Pernía, Abigail Montero-Calderon, Francisco Javier Tingo-Jácome, Leslie Espinoza, Lilian Maritza Spencer
Serological Cross-Reaction between Six Thiadiazine by Indirect ELISA Test and Their Antimicrobial Activity. Methods and protocols 6 (2) (2023)